Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer
- PMID: 24698959
- PMCID: PMC4074802
- DOI: 10.3390/cancers6020756
Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer
Abstract
Head and neck squamous cell carcinoma (HNSCC) is marked by immunosuppression, a state in which the established tumor escapes immune attack. However, the impact of the premalignant and tumor microenvironments on immune reactivity has yet to be elucidated. The purpose of this study was to determine how soluble mediators from cells established from carcinogen-induced oral premalignant lesions and HNSCC modulate immune cell cytokine production. It was found that premalignant cells secrete significantly increased levels of G-CSF, RANTES, MCP-1, and PGE2 compared to HNSCC cells. Splenocytes incubated with premalignant supernatant secreted significantly increased levels of Th1-, Th2-, and Th17-associated cytokines compared to splenocytes incubated with HNSCC supernatant. These studies demonstrate that whereas the premalignant microenvironment elicits proinflammatory cytokine production, the tumor microenvironment is significantly less immune stimulatory and may contribute to immunosuppression in established HNSCC.
Figures



Similar articles
-
An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.J Clin Cell Immunol. 2014 Jun;5(3):230. doi: 10.4172/2155-9899.1000230. J Clin Cell Immunol. 2014. PMID: 25419481 Free PMC article.
-
Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells.Anticancer Res. 2016 Jul;36(7):3261-70. Anticancer Res. 2016. PMID: 27354582 Free PMC article.
-
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer.Front Immunol. 2016 Sep 22;7:379. doi: 10.3389/fimmu.2016.00379. eCollection 2016. Front Immunol. 2016. PMID: 27713748 Free PMC article.
-
[Immunotherapies for head and neck squamous cell carcinomas].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jul 5;31(13):1050-1056. doi: 10.13201/j.issn.1001-1781.2017.13.024. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 29798179 Review. Chinese.
-
Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer.Immunol Res. 2012 Dec;54(1-3):266-74. doi: 10.1007/s12026-012-8306-6. Immunol Res. 2012. PMID: 22454102 Review.
Cited by
-
The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.Front Immunol. 2022 Jun 16;13:894021. doi: 10.3389/fimmu.2022.894021. eCollection 2022. Front Immunol. 2022. PMID: 35784290 Free PMC article. Review.
-
Hypoxic Transformation of Immune Cell Metabolism Within the Microenvironment of Oral Cancers.Front Oral Health. 2020 Dec 16;1:585710. doi: 10.3389/froh.2020.585710. eCollection 2020. Front Oral Health. 2020. PMID: 35047983 Free PMC article. Review.
-
Profiles of immune cell infiltration in head and neck squamous carcinoma.Biosci Rep. 2020 Feb 28;40(2):BSR20192724. doi: 10.1042/BSR20192724. Biosci Rep. 2020. PMID: 32095823 Free PMC article.
-
Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention.Curr Treat Options Oncol. 2021 May 15;22(6):52. doi: 10.1007/s11864-021-00848-x. Curr Treat Options Oncol. 2021. PMID: 33991232 Free PMC article. Review.
-
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies.Cancers (Basel). 2021 Jul 23;13(15):3696. doi: 10.3390/cancers13153696. Cancers (Basel). 2021. PMID: 34359597 Free PMC article. Review.
References
-
- Bergmann C., Strauss L., Wang Y., Szczepanski M.J., Lang S., Johnson J.T., Whiteside T.L. T regulatory type I cells in squamous cell carcinoma of the head and neck: Mechanisms of suppression and expansion in advanced disease. Clin. Cancer Res. 2008;14:3706–3715. doi: 10.1158/1078-0432.CCR-07-5126. - DOI - PMC - PubMed
-
- Badoual C., Hans S., Rodriguez J., Peyrard S., Klein C., Agueznay Nel H., Mosseri V., Laccourreye O., Bruneval P., Fridman W.H., et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin. Cancer Res. 2006;12:465–472. doi: 10.1158/1078-0432.CCR-05-1886. - DOI - PubMed
-
- Young M.R., Wright M.A., Lozano Y., Prechel M.M., Benefield J., Leonetti J.P., Collins S.L., Petruzzelli G.J. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int. J. Cancer. 1997;74:69–74. doi: 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous